Fig. 7.

Central macular thickness (A) and BCVA (B) after a single injection of triamcinolone or bevacizumab.38 *P < 0.05 and **P < 0.01 for within-group changes from baseline. Reproduced from Paccola L, et al. Br J Ophthalmol 2008;92:76–80, with permission from BMJ Publishing Group Ltd. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.